nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2C19—epilepsy syndrome	0.135	0.574	CbGaD
Almotriptan—CYP2D6—epilepsy syndrome	0.1	0.426	CbGaD
Almotriptan—MAOA—Zonisamide—epilepsy syndrome	0.0328	0.0679	CbGbCtD
Almotriptan—CYP2E1—Felbamate—epilepsy syndrome	0.0204	0.0423	CbGbCtD
Almotriptan—CYP2E1—Trimethadione—epilepsy syndrome	0.0204	0.0423	CbGbCtD
Almotriptan—CYP2E1—Clonazepam—epilepsy syndrome	0.0174	0.036	CbGbCtD
Almotriptan—CYP2C8—Trimethadione—epilepsy syndrome	0.0153	0.0316	CbGbCtD
Almotriptan—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0144	0.0297	CbGbCtD
Almotriptan—CYP2E1—Rufinamide—epilepsy syndrome	0.0142	0.0293	CbGbCtD
Almotriptan—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0138	0.0285	CbGbCtD
Almotriptan—CYP2C19—Trimethadione—epilepsy syndrome	0.0128	0.0265	CbGbCtD
Almotriptan—CYP2C19—Felbamate—epilepsy syndrome	0.0128	0.0265	CbGbCtD
Almotriptan—CYP2C19—Fosphenytoin—epilepsy syndrome	0.012	0.0249	CbGbCtD
Almotriptan—CYP2E1—Propofol—epilepsy syndrome	0.0116	0.0239	CbGbCtD
Almotriptan—CYP2E1—Phenobarbital—epilepsy syndrome	0.011	0.0229	CbGbCtD
Almotriptan—CYP2E1—Midazolam—epilepsy syndrome	0.0109	0.0225	CbGbCtD
Almotriptan—CYP2E1—Diazepam—epilepsy syndrome	0.0105	0.0217	CbGbCtD
Almotriptan—CYP2C19—Clobazam—epilepsy syndrome	0.0104	0.0216	CbGbCtD
Almotriptan—CYP2C8—Carbamazepine—epilepsy syndrome	0.0103	0.0214	CbGbCtD
Almotriptan—CYP2C8—Primidone—epilepsy syndrome	0.00963	0.0199	CbGbCtD
Almotriptan—HTR1D—meninx—epilepsy syndrome	0.00948	0.249	CbGeAlD
Almotriptan—CYP2C8—Phenytoin—epilepsy syndrome	0.00925	0.0192	CbGbCtD
Almotriptan—CYP2C19—Carbamazepine—epilepsy syndrome	0.00865	0.0179	CbGbCtD
Almotriptan—CYP2C8—Propofol—epilepsy syndrome	0.00863	0.0179	CbGbCtD
Almotriptan—CYP2C8—Phenobarbital—epilepsy syndrome	0.00825	0.0171	CbGbCtD
Almotriptan—CYP2C19—Primidone—epilepsy syndrome	0.00808	0.0167	CbGbCtD
Almotriptan—CYP1A2—Carbamazepine—epilepsy syndrome	0.00799	0.0165	CbGbCtD
Almotriptan—CYP2C8—Diazepam—epilepsy syndrome	0.00782	0.0162	CbGbCtD
Almotriptan—CYP2C19—Phenytoin—epilepsy syndrome	0.00776	0.0161	CbGbCtD
Almotriptan—CYP1A2—Primidone—epilepsy syndrome	0.00746	0.0154	CbGbCtD
Almotriptan—CYP2C19—Propofol—epilepsy syndrome	0.00724	0.015	CbGbCtD
Almotriptan—CYP2C19—Phenobarbital—epilepsy syndrome	0.00692	0.0143	CbGbCtD
Almotriptan—CYP1A2—Propofol—epilepsy syndrome	0.00668	0.0138	CbGbCtD
Almotriptan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00666	0.0138	CbGbCtD
Almotriptan—CYP2C19—Diazepam—epilepsy syndrome	0.00656	0.0136	CbGbCtD
Almotriptan—CYP2C19—Zonisamide—epilepsy syndrome	0.0064	0.0133	CbGbCtD
Almotriptan—CYP1A2—Phenobarbital—epilepsy syndrome	0.00638	0.0132	CbGbCtD
Almotriptan—CYP3A4—Trimethadione—epilepsy syndrome	0.00619	0.0128	CbGbCtD
Almotriptan—CYP3A4—Felbamate—epilepsy syndrome	0.00619	0.0128	CbGbCtD
Almotriptan—CYP2C8—Valproic Acid—epilepsy syndrome	0.00616	0.0128	CbGbCtD
Almotriptan—CYP1A2—Diazepam—epilepsy syndrome	0.00605	0.0125	CbGbCtD
Almotriptan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00582	0.0121	CbGbCtD
Almotriptan—CYP2D6—Propofol—epilepsy syndrome	0.0055	0.0114	CbGbCtD
Almotriptan—CYP3A4—Clonazepam—epilepsy syndrome	0.00527	0.0109	CbGbCtD
Almotriptan—CYP2C19—Valproic Acid—epilepsy syndrome	0.00517	0.0107	CbGbCtD
Almotriptan—CYP3A4—Clobazam—epilepsy syndrome	0.00505	0.0105	CbGbCtD
Almotriptan—CYP1A2—Valproic Acid—epilepsy syndrome	0.00477	0.00988	CbGbCtD
Almotriptan—CYP2C19—Topiramate—epilepsy syndrome	0.00467	0.00966	CbGbCtD
Almotriptan—CYP3A4—Rufinamide—epilepsy syndrome	0.00429	0.00889	CbGbCtD
Almotriptan—CYP3A4—Carbamazepine—epilepsy syndrome	0.00418	0.00866	CbGbCtD
Almotriptan—CYP3A4—Primidone—epilepsy syndrome	0.00391	0.00809	CbGbCtD
Almotriptan—CYP3A4—Phenytoin—epilepsy syndrome	0.00375	0.00777	CbGbCtD
Almotriptan—CYP3A4—Propofol—epilepsy syndrome	0.0035	0.00725	CbGbCtD
Almotriptan—MAOA—locus ceruleus—epilepsy syndrome	0.00349	0.0917	CbGeAlD
Almotriptan—CYP3A4—Acetazolamide—epilepsy syndrome	0.00334	0.00693	CbGbCtD
Almotriptan—CYP3A4—Phenobarbital—epilepsy syndrome	0.00334	0.00693	CbGbCtD
Almotriptan—CYP3A4—Midazolam—epilepsy syndrome	0.0033	0.00683	CbGbCtD
Almotriptan—CYP3A4—Diazepam—epilepsy syndrome	0.00317	0.00657	CbGbCtD
Almotriptan—CYP3A4—Zonisamide—epilepsy syndrome	0.00309	0.00641	CbGbCtD
Almotriptan—CYP3A4—Valproic Acid—epilepsy syndrome	0.0025	0.00518	CbGbCtD
Almotriptan—CYP3A4—Topiramate—epilepsy syndrome	0.00226	0.00467	CbGbCtD
Almotriptan—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00224	0.059	CbGeAlD
Almotriptan—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00217	0.0571	CbGeAlD
Almotriptan—HTR1B—ganglion—epilepsy syndrome	0.0014	0.0367	CbGeAlD
Almotriptan—HTR1D—ganglion—epilepsy syndrome	0.00135	0.0355	CbGeAlD
Almotriptan—MAOA—ganglion—epilepsy syndrome	0.00103	0.0271	CbGeAlD
Almotriptan—MAOA—hindbrain—epilepsy syndrome	0.000781	0.0205	CbGeAlD
Almotriptan—Sumatriptan—SLCO1A2—epilepsy syndrome	0.000747	0.348	CrCbGaD
Almotriptan—HTR1B—brainstem—epilepsy syndrome	0.000607	0.016	CbGeAlD
Almotriptan—HTR1D—brainstem—epilepsy syndrome	0.000588	0.0154	CbGeAlD
Almotriptan—HTR1B—forebrain—epilepsy syndrome	0.000586	0.0154	CbGeAlD
Almotriptan—FMO3—head—epilepsy syndrome	0.000572	0.015	CbGeAlD
Almotriptan—HTR1D—forebrain—epilepsy syndrome	0.000567	0.0149	CbGeAlD
Almotriptan—FMO3—nervous system—epilepsy syndrome	0.000542	0.0142	CbGeAlD
Almotriptan—HTR1B—telencephalon—epilepsy syndrome	0.000539	0.0142	CbGeAlD
Almotriptan—FMO3—central nervous system—epilepsy syndrome	0.000522	0.0137	CbGeAlD
Almotriptan—HTR1D—telencephalon—epilepsy syndrome	0.000522	0.0137	CbGeAlD
Almotriptan—CYP2D6—hindbrain—epilepsy syndrome	0.000464	0.0122	CbGeAlD
Almotriptan—MAOA—brainstem—epilepsy syndrome	0.000448	0.0118	CbGeAlD
Almotriptan—MAOA—forebrain—epilepsy syndrome	0.000432	0.0114	CbGeAlD
Almotriptan—FMO3—brain—epilepsy syndrome	0.000414	0.0109	CbGeAlD
Almotriptan—MAOA—telencephalon—epilepsy syndrome	0.000397	0.0104	CbGeAlD
Almotriptan—HTR1B—midbrain—epilepsy syndrome	0.000387	0.0102	CbGeAlD
Almotriptan—HTR1B—spinal cord—epilepsy syndrome	0.000378	0.00992	CbGeAlD
Almotriptan—HTR1D—midbrain—epilepsy syndrome	0.000375	0.00984	CbGeAlD
Almotriptan—HTR1B—head—epilepsy syndrome	0.000336	0.00882	CbGeAlD
Almotriptan—HTR1D—head—epilepsy syndrome	0.000325	0.00854	CbGeAlD
Almotriptan—Eletriptan—HTR7—epilepsy syndrome	0.000324	0.151	CrCbGaD
Almotriptan—HTR1B—nervous system—epilepsy syndrome	0.000318	0.00836	CbGeAlD
Almotriptan—Sumatriptan—ABCG2—epilepsy syndrome	0.000316	0.147	CrCbGaD
Almotriptan—MAOA—medulla oblongata—epilepsy syndrome	0.000312	0.0082	CbGeAlD
Almotriptan—HTR1D—nervous system—epilepsy syndrome	0.000308	0.00809	CbGeAlD
Almotriptan—HTR1B—central nervous system—epilepsy syndrome	0.000306	0.00805	CbGeAlD
Almotriptan—CYP2E1—telencephalon—epilepsy syndrome	0.000298	0.00783	CbGeAlD
Almotriptan—HTR1D—central nervous system—epilepsy syndrome	0.000297	0.00779	CbGeAlD
Almotriptan—MAOA—midbrain—epilepsy syndrome	0.000285	0.0075	CbGeAlD
Almotriptan—MAOA—spinal cord—epilepsy syndrome	0.000278	0.00731	CbGeAlD
Almotriptan—CYP2D6—brainstem—epilepsy syndrome	0.000266	0.00699	CbGeAlD
Almotriptan—CYP2D6—forebrain—epilepsy syndrome	0.000257	0.00675	CbGeAlD
Almotriptan—MAOA—head—epilepsy syndrome	0.000247	0.0065	CbGeAlD
Almotriptan—HTR1B—brain—epilepsy syndrome	0.000243	0.00639	CbGeAlD
Almotriptan—CYP2D6—telencephalon—epilepsy syndrome	0.000236	0.0062	CbGeAlD
Almotriptan—HTR1D—brain—epilepsy syndrome	0.000235	0.00619	CbGeAlD
Almotriptan—MAOA—nervous system—epilepsy syndrome	0.000235	0.00616	CbGeAlD
Almotriptan—CYP2E1—medulla oblongata—epilepsy syndrome	0.000234	0.00616	CbGeAlD
Almotriptan—MAOA—central nervous system—epilepsy syndrome	0.000226	0.00593	CbGeAlD
Almotriptan—MAOA—cerebellum—epilepsy syndrome	0.000221	0.0058	CbGeAlD
Almotriptan—CYP2E1—spinal cord—epilepsy syndrome	0.000209	0.00549	CbGeAlD
Almotriptan—Eletriptan—CYP2C19—epilepsy syndrome	0.000201	0.0935	CrCbGaD
Almotriptan—CYP2E1—head—epilepsy syndrome	0.000186	0.00488	CbGeAlD
Almotriptan—MAOA—brain—epilepsy syndrome	0.000179	0.00471	CbGeAlD
Almotriptan—CYP2E1—nervous system—epilepsy syndrome	0.000176	0.00462	CbGeAlD
Almotriptan—Melatonin—CYP2C19—epilepsy syndrome	0.000174	0.0811	CrCbGaD
Almotriptan—CYP2E1—central nervous system—epilepsy syndrome	0.000169	0.00445	CbGeAlD
Almotriptan—CYP2E1—cerebellum—epilepsy syndrome	0.000166	0.00435	CbGeAlD
Almotriptan—CYP2C8—brain—epilepsy syndrome	0.00016	0.0042	CbGeAlD
Almotriptan—Eletriptan—CYP2D6—epilepsy syndrome	0.000149	0.0693	CrCbGaD
Almotriptan—CYP2D6—head—epilepsy syndrome	0.000147	0.00386	CbGeAlD
Almotriptan—CYP3A4—nervous system—epilepsy syndrome	0.000142	0.00372	CbGeAlD
Almotriptan—CYP2D6—nervous system—epilepsy syndrome	0.000139	0.00366	CbGeAlD
Almotriptan—CYP3A4—central nervous system—epilepsy syndrome	0.000136	0.00358	CbGeAlD
Almotriptan—CYP2E1—brain—epilepsy syndrome	0.000135	0.00354	CbGeAlD
Almotriptan—CYP2D6—central nervous system—epilepsy syndrome	0.000134	0.00353	CbGeAlD
Almotriptan—Sumatriptan—ABCB1—epilepsy syndrome	0.000131	0.0612	CrCbGaD
Almotriptan—CYP2D6—cerebellum—epilepsy syndrome	0.000131	0.00345	CbGeAlD
Almotriptan—CYP2D6—brain—epilepsy syndrome	0.000107	0.0028	CbGeAlD
Almotriptan—Eletriptan—ABCB1—epilepsy syndrome	0.000106	0.0495	CrCbGaD
Almotriptan—Headache—Fosphenytoin—epilepsy syndrome	5.04e-05	0.000294	CcSEcCtD
Almotriptan—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.04e-05	0.000293	CcSEcCtD
Almotriptan—Palpitations—Pregabalin—epilepsy syndrome	5.03e-05	0.000293	CcSEcCtD
Almotriptan—Asthenia—Phenytoin—epilepsy syndrome	5.03e-05	0.000293	CcSEcCtD
Almotriptan—Nausea—Midazolam—epilepsy syndrome	5.02e-05	0.000292	CcSEcCtD
Almotriptan—Hypoaesthesia—Topiramate—epilepsy syndrome	5.02e-05	0.000292	CcSEcCtD
Almotriptan—Tachycardia—Valproic Acid—epilepsy syndrome	5.01e-05	0.000292	CcSEcCtD
Almotriptan—Diarrhoea—Zonisamide—epilepsy syndrome	5.01e-05	0.000292	CcSEcCtD
Almotriptan—Pharyngitis—Topiramate—epilepsy syndrome	5.01e-05	0.000292	CcSEcCtD
Almotriptan—Loss of consciousness—Pregabalin—epilepsy syndrome	5e-05	0.000291	CcSEcCtD
Almotriptan—Asthenia—Oxcarbazepine—epilepsy syndrome	5e-05	0.000291	CcSEcCtD
Almotriptan—Pruritus—Clonazepam—epilepsy syndrome	4.99e-05	0.000291	CcSEcCtD
Almotriptan—Vomiting—Vigabatrin—epilepsy syndrome	4.99e-05	0.000291	CcSEcCtD
Almotriptan—Skin disorder—Valproic Acid—epilepsy syndrome	4.99e-05	0.000291	CcSEcCtD
Almotriptan—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.97e-05	0.000289	CcSEcCtD
Almotriptan—Pruritus—Phenytoin—epilepsy syndrome	4.96e-05	0.000289	CcSEcCtD
Almotriptan—Nausea—Levetiracetam—epilepsy syndrome	4.96e-05	0.000289	CcSEcCtD
Almotriptan—Rash—Vigabatrin—epilepsy syndrome	4.95e-05	0.000288	CcSEcCtD
Almotriptan—Dizziness—Felbamate—epilepsy syndrome	4.95e-05	0.000288	CcSEcCtD
Almotriptan—Dermatitis—Vigabatrin—epilepsy syndrome	4.94e-05	0.000288	CcSEcCtD
Almotriptan—Pruritus—Oxcarbazepine—epilepsy syndrome	4.93e-05	0.000287	CcSEcCtD
Almotriptan—Convulsion—Pregabalin—epilepsy syndrome	4.93e-05	0.000287	CcSEcCtD
Almotriptan—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.93e-05	0.000287	CcSEcCtD
Almotriptan—Vision blurred—Gabapentin—epilepsy syndrome	4.92e-05	0.000286	CcSEcCtD
Almotriptan—Headache—Vigabatrin—epilepsy syndrome	4.92e-05	0.000286	CcSEcCtD
Almotriptan—Hypertension—Pregabalin—epilepsy syndrome	4.91e-05	0.000286	CcSEcCtD
Almotriptan—Vomiting—Diazepam—epilepsy syndrome	4.91e-05	0.000286	CcSEcCtD
Almotriptan—Tremor—Gabapentin—epilepsy syndrome	4.89e-05	0.000285	CcSEcCtD
Almotriptan—Rash—Diazepam—epilepsy syndrome	4.87e-05	0.000284	CcSEcCtD
Almotriptan—Dermatitis—Diazepam—epilepsy syndrome	4.87e-05	0.000284	CcSEcCtD
Almotriptan—Visual impairment—Topiramate—epilepsy syndrome	4.86e-05	0.000283	CcSEcCtD
Almotriptan—Myalgia—Pregabalin—epilepsy syndrome	4.84e-05	0.000282	CcSEcCtD
Almotriptan—Chest pain—Pregabalin—epilepsy syndrome	4.84e-05	0.000282	CcSEcCtD
Almotriptan—Arthralgia—Pregabalin—epilepsy syndrome	4.84e-05	0.000282	CcSEcCtD
Almotriptan—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.84e-05	0.000282	CcSEcCtD
Almotriptan—Dizziness—Zonisamide—epilepsy syndrome	4.84e-05	0.000282	CcSEcCtD
Almotriptan—Headache—Diazepam—epilepsy syndrome	4.84e-05	0.000282	CcSEcCtD
Almotriptan—Anxiety—Pregabalin—epilepsy syndrome	4.83e-05	0.000281	CcSEcCtD
Almotriptan—Diarrhoea—Clonazepam—epilepsy syndrome	4.83e-05	0.000281	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.81e-05	0.00028	CcSEcCtD
Almotriptan—Asthenia—Carbamazepine—epilepsy syndrome	4.8e-05	0.00028	CcSEcCtD
Almotriptan—Agitation—Gabapentin—epilepsy syndrome	4.8e-05	0.000279	CcSEcCtD
Almotriptan—Diarrhoea—Phenytoin—epilepsy syndrome	4.79e-05	0.000279	CcSEcCtD
Almotriptan—Discomfort—Pregabalin—epilepsy syndrome	4.79e-05	0.000279	CcSEcCtD
Almotriptan—Nausea—Fosphenytoin—epilepsy syndrome	4.78e-05	0.000279	CcSEcCtD
Almotriptan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.77e-05	0.000278	CcSEcCtD
Almotriptan—Angioedema—Gabapentin—epilepsy syndrome	4.77e-05	0.000278	CcSEcCtD
Almotriptan—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.76e-05	0.000277	CcSEcCtD
Almotriptan—Vomiting—Felbamate—epilepsy syndrome	4.76e-05	0.000277	CcSEcCtD
Almotriptan—Dry mouth—Pregabalin—epilepsy syndrome	4.74e-05	0.000276	CcSEcCtD
Almotriptan—Pruritus—Carbamazepine—epilepsy syndrome	4.73e-05	0.000276	CcSEcCtD
Almotriptan—Rash—Felbamate—epilepsy syndrome	4.72e-05	0.000275	CcSEcCtD
Almotriptan—Eye disorder—Topiramate—epilepsy syndrome	4.71e-05	0.000275	CcSEcCtD
Almotriptan—Dermatitis—Felbamate—epilepsy syndrome	4.71e-05	0.000274	CcSEcCtD
Almotriptan—Malaise—Gabapentin—epilepsy syndrome	4.71e-05	0.000274	CcSEcCtD
Almotriptan—Tinnitus—Topiramate—epilepsy syndrome	4.7e-05	0.000274	CcSEcCtD
Almotriptan—Vertigo—Gabapentin—epilepsy syndrome	4.69e-05	0.000273	CcSEcCtD
Almotriptan—Headache—Felbamate—epilepsy syndrome	4.69e-05	0.000273	CcSEcCtD
Almotriptan—Confusional state—Pregabalin—epilepsy syndrome	4.68e-05	0.000273	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.68e-05	0.000273	CcSEcCtD
Almotriptan—Cardiac disorder—Topiramate—epilepsy syndrome	4.68e-05	0.000273	CcSEcCtD
Almotriptan—Syncope—Gabapentin—epilepsy syndrome	4.68e-05	0.000273	CcSEcCtD
Almotriptan—Dizziness—Clonazepam—epilepsy syndrome	4.67e-05	0.000272	CcSEcCtD
Almotriptan—Nausea—Vigabatrin—epilepsy syndrome	4.66e-05	0.000272	CcSEcCtD
Almotriptan—Vomiting—Zonisamide—epilepsy syndrome	4.65e-05	0.000271	CcSEcCtD
Almotriptan—Insomnia—Valproic Acid—epilepsy syndrome	4.65e-05	0.000271	CcSEcCtD
Almotriptan—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.64e-05	0.000271	CcSEcCtD
Almotriptan—Asthenia—Lamotrigine—epilepsy syndrome	4.64e-05	0.00027	CcSEcCtD
Almotriptan—Dizziness—Phenytoin—epilepsy syndrome	4.63e-05	0.00027	CcSEcCtD
Almotriptan—Rash—Zonisamide—epilepsy syndrome	4.62e-05	0.000269	CcSEcCtD
Almotriptan—Paraesthesia—Valproic Acid—epilepsy syndrome	4.61e-05	0.000269	CcSEcCtD
Almotriptan—Palpitations—Gabapentin—epilepsy syndrome	4.61e-05	0.000269	CcSEcCtD
Almotriptan—Dermatitis—Zonisamide—epilepsy syndrome	4.61e-05	0.000269	CcSEcCtD
Almotriptan—Dizziness—Oxcarbazepine—epilepsy syndrome	4.61e-05	0.000269	CcSEcCtD
Almotriptan—Nausea—Diazepam—epilepsy syndrome	4.59e-05	0.000267	CcSEcCtD
Almotriptan—Loss of consciousness—Gabapentin—epilepsy syndrome	4.59e-05	0.000267	CcSEcCtD
Almotriptan—Headache—Zonisamide—epilepsy syndrome	4.59e-05	0.000267	CcSEcCtD
Almotriptan—Dyspnoea—Valproic Acid—epilepsy syndrome	4.58e-05	0.000267	CcSEcCtD
Almotriptan—Diarrhoea—Carbamazepine—epilepsy syndrome	4.58e-05	0.000267	CcSEcCtD
Almotriptan—Pruritus—Lamotrigine—epilepsy syndrome	4.57e-05	0.000266	CcSEcCtD
Almotriptan—Shock—Pregabalin—epilepsy syndrome	4.57e-05	0.000266	CcSEcCtD
Almotriptan—Somnolence—Valproic Acid—epilepsy syndrome	4.57e-05	0.000266	CcSEcCtD
Almotriptan—Immune system disorder—Topiramate—epilepsy syndrome	4.56e-05	0.000265	CcSEcCtD
Almotriptan—Nervous system disorder—Pregabalin—epilepsy syndrome	4.55e-05	0.000265	CcSEcCtD
Almotriptan—Tachycardia—Pregabalin—epilepsy syndrome	4.53e-05	0.000264	CcSEcCtD
Almotriptan—Chills—Topiramate—epilepsy syndrome	4.53e-05	0.000264	CcSEcCtD
Almotriptan—Dyspepsia—Valproic Acid—epilepsy syndrome	4.52e-05	0.000263	CcSEcCtD
Almotriptan—Convulsion—Gabapentin—epilepsy syndrome	4.52e-05	0.000263	CcSEcCtD
Almotriptan—Skin disorder—Pregabalin—epilepsy syndrome	4.51e-05	0.000263	CcSEcCtD
Almotriptan—Hypertension—Gabapentin—epilepsy syndrome	4.51e-05	0.000262	CcSEcCtD
Almotriptan—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.49e-05	0.000262	CcSEcCtD
Almotriptan—Vomiting—Clonazepam—epilepsy syndrome	4.49e-05	0.000261	CcSEcCtD
Almotriptan—Vomiting—Phenytoin—epilepsy syndrome	4.46e-05	0.00026	CcSEcCtD
Almotriptan—Rash—Clonazepam—epilepsy syndrome	4.45e-05	0.000259	CcSEcCtD
Almotriptan—Dermatitis—Clonazepam—epilepsy syndrome	4.44e-05	0.000259	CcSEcCtD
Almotriptan—Arthralgia—Gabapentin—epilepsy syndrome	4.44e-05	0.000259	CcSEcCtD
Almotriptan—Chest pain—Gabapentin—epilepsy syndrome	4.44e-05	0.000259	CcSEcCtD
Almotriptan—Myalgia—Gabapentin—epilepsy syndrome	4.44e-05	0.000259	CcSEcCtD
Almotriptan—Nausea—Felbamate—epilepsy syndrome	4.44e-05	0.000259	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.44e-05	0.000258	CcSEcCtD
Almotriptan—Vomiting—Oxcarbazepine—epilepsy syndrome	4.43e-05	0.000258	CcSEcCtD
Almotriptan—Fatigue—Valproic Acid—epilepsy syndrome	4.43e-05	0.000258	CcSEcCtD
Almotriptan—Anxiety—Gabapentin—epilepsy syndrome	4.43e-05	0.000258	CcSEcCtD
Almotriptan—Dizziness—Carbamazepine—epilepsy syndrome	4.42e-05	0.000258	CcSEcCtD
Almotriptan—Diarrhoea—Lamotrigine—epilepsy syndrome	4.42e-05	0.000258	CcSEcCtD
Almotriptan—Headache—Clonazepam—epilepsy syndrome	4.42e-05	0.000257	CcSEcCtD
Almotriptan—Rash—Phenytoin—epilepsy syndrome	4.42e-05	0.000257	CcSEcCtD
Almotriptan—Mental disorder—Topiramate—epilepsy syndrome	4.42e-05	0.000257	CcSEcCtD
Almotriptan—Dermatitis—Phenytoin—epilepsy syndrome	4.41e-05	0.000257	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.41e-05	0.000257	CcSEcCtD
Almotriptan—Rash—Oxcarbazepine—epilepsy syndrome	4.4e-05	0.000256	CcSEcCtD
Almotriptan—Pain—Valproic Acid—epilepsy syndrome	4.39e-05	0.000256	CcSEcCtD
Almotriptan—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.39e-05	0.000256	CcSEcCtD
Almotriptan—Headache—Phenytoin—epilepsy syndrome	4.39e-05	0.000256	CcSEcCtD
Almotriptan—Erythema—Topiramate—epilepsy syndrome	4.39e-05	0.000256	CcSEcCtD
Almotriptan—Discomfort—Gabapentin—epilepsy syndrome	4.39e-05	0.000256	CcSEcCtD
Almotriptan—Headache—Oxcarbazepine—epilepsy syndrome	4.37e-05	0.000254	CcSEcCtD
Almotriptan—Nausea—Zonisamide—epilepsy syndrome	4.35e-05	0.000253	CcSEcCtD
Almotriptan—Dry mouth—Gabapentin—epilepsy syndrome	4.34e-05	0.000253	CcSEcCtD
Almotriptan—Tension—Topiramate—epilepsy syndrome	4.31e-05	0.000251	CcSEcCtD
Almotriptan—Dysgeusia—Topiramate—epilepsy syndrome	4.3e-05	0.00025	CcSEcCtD
Almotriptan—Confusional state—Gabapentin—epilepsy syndrome	4.29e-05	0.00025	CcSEcCtD
Almotriptan—Dizziness—Lamotrigine—epilepsy syndrome	4.28e-05	0.000249	CcSEcCtD
Almotriptan—Nervousness—Topiramate—epilepsy syndrome	4.26e-05	0.000248	CcSEcCtD
Almotriptan—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.26e-05	0.000248	CcSEcCtD
Almotriptan—Vomiting—Carbamazepine—epilepsy syndrome	4.25e-05	0.000248	CcSEcCtD
Almotriptan—Back pain—Topiramate—epilepsy syndrome	4.25e-05	0.000247	CcSEcCtD
Almotriptan—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.23e-05	0.000247	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.23e-05	0.000247	CcSEcCtD
Almotriptan—Rash—Carbamazepine—epilepsy syndrome	4.22e-05	0.000246	CcSEcCtD
Almotriptan—Dermatitis—Carbamazepine—epilepsy syndrome	4.21e-05	0.000245	CcSEcCtD
Almotriptan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.2e-05	0.000245	CcSEcCtD
Almotriptan—Insomnia—Pregabalin—epilepsy syndrome	4.2e-05	0.000245	CcSEcCtD
Almotriptan—Nausea—Clonazepam—epilepsy syndrome	4.19e-05	0.000244	CcSEcCtD
Almotriptan—Headache—Carbamazepine—epilepsy syndrome	4.19e-05	0.000244	CcSEcCtD
Almotriptan—Shock—Gabapentin—epilepsy syndrome	4.19e-05	0.000244	CcSEcCtD
Almotriptan—Nervous system disorder—Gabapentin—epilepsy syndrome	4.18e-05	0.000243	CcSEcCtD
Almotriptan—Paraesthesia—Pregabalin—epilepsy syndrome	4.17e-05	0.000243	CcSEcCtD
Almotriptan—Nausea—Phenytoin—epilepsy syndrome	4.16e-05	0.000242	CcSEcCtD
Almotriptan—Tachycardia—Gabapentin—epilepsy syndrome	4.16e-05	0.000242	CcSEcCtD
Almotriptan—Dyspnoea—Pregabalin—epilepsy syndrome	4.14e-05	0.000241	CcSEcCtD
Almotriptan—Nausea—Oxcarbazepine—epilepsy syndrome	4.14e-05	0.000241	CcSEcCtD
Almotriptan—Vision blurred—Topiramate—epilepsy syndrome	4.14e-05	0.000241	CcSEcCtD
Almotriptan—Skin disorder—Gabapentin—epilepsy syndrome	4.14e-05	0.000241	CcSEcCtD
Almotriptan—Somnolence—Pregabalin—epilepsy syndrome	4.13e-05	0.000241	CcSEcCtD
Almotriptan—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.12e-05	0.00024	CcSEcCtD
Almotriptan—Tremor—Topiramate—epilepsy syndrome	4.11e-05	0.00024	CcSEcCtD
Almotriptan—Vomiting—Lamotrigine—epilepsy syndrome	4.11e-05	0.000239	CcSEcCtD
Almotriptan—Rash—Lamotrigine—epilepsy syndrome	4.08e-05	0.000237	CcSEcCtD
Almotriptan—Ill-defined disorder—Topiramate—epilepsy syndrome	4.07e-05	0.000237	CcSEcCtD
Almotriptan—Dermatitis—Lamotrigine—epilepsy syndrome	4.07e-05	0.000237	CcSEcCtD
Almotriptan—Abdominal pain—Valproic Acid—epilepsy syndrome	4.06e-05	0.000237	CcSEcCtD
Almotriptan—Body temperature increased—Valproic Acid—epilepsy syndrome	4.06e-05	0.000237	CcSEcCtD
Almotriptan—Headache—Lamotrigine—epilepsy syndrome	4.05e-05	0.000236	CcSEcCtD
Almotriptan—Agitation—Topiramate—epilepsy syndrome	4.03e-05	0.000235	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.01e-05	0.000234	CcSEcCtD
Almotriptan—Fatigue—Pregabalin—epilepsy syndrome	4e-05	0.000233	CcSEcCtD
Almotriptan—Nausea—Carbamazepine—epilepsy syndrome	3.97e-05	0.000231	CcSEcCtD
Almotriptan—Pain—Pregabalin—epilepsy syndrome	3.97e-05	0.000231	CcSEcCtD
Almotriptan—Malaise—Topiramate—epilepsy syndrome	3.96e-05	0.000231	CcSEcCtD
Almotriptan—Vertigo—Topiramate—epilepsy syndrome	3.94e-05	0.00023	CcSEcCtD
Almotriptan—Syncope—Topiramate—epilepsy syndrome	3.94e-05	0.000229	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.88e-05	0.000226	CcSEcCtD
Almotriptan—Palpitations—Topiramate—epilepsy syndrome	3.88e-05	0.000226	CcSEcCtD
Almotriptan—Loss of consciousness—Topiramate—epilepsy syndrome	3.86e-05	0.000225	CcSEcCtD
Almotriptan—Insomnia—Gabapentin—epilepsy syndrome	3.85e-05	0.000224	CcSEcCtD
Almotriptan—Nausea—Lamotrigine—epilepsy syndrome	3.84e-05	0.000224	CcSEcCtD
Almotriptan—Feeling abnormal—Pregabalin—epilepsy syndrome	3.83e-05	0.000223	CcSEcCtD
Almotriptan—Paraesthesia—Gabapentin—epilepsy syndrome	3.82e-05	0.000223	CcSEcCtD
Almotriptan—Convulsion—Topiramate—epilepsy syndrome	3.8e-05	0.000222	CcSEcCtD
Almotriptan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.8e-05	0.000221	CcSEcCtD
Almotriptan—Dyspnoea—Gabapentin—epilepsy syndrome	3.8e-05	0.000221	CcSEcCtD
Almotriptan—Hypertension—Topiramate—epilepsy syndrome	3.79e-05	0.000221	CcSEcCtD
Almotriptan—Somnolence—Gabapentin—epilepsy syndrome	3.79e-05	0.000221	CcSEcCtD
Almotriptan—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.79e-05	0.00022	CcSEcCtD
Almotriptan—Dyspepsia—Gabapentin—epilepsy syndrome	3.75e-05	0.000218	CcSEcCtD
Almotriptan—Myalgia—Topiramate—epilepsy syndrome	3.74e-05	0.000218	CcSEcCtD
Almotriptan—Chest pain—Topiramate—epilepsy syndrome	3.74e-05	0.000218	CcSEcCtD
Almotriptan—Arthralgia—Topiramate—epilepsy syndrome	3.74e-05	0.000218	CcSEcCtD
Almotriptan—Anxiety—Topiramate—epilepsy syndrome	3.72e-05	0.000217	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.71e-05	0.000216	CcSEcCtD
Almotriptan—Discomfort—Topiramate—epilepsy syndrome	3.69e-05	0.000215	CcSEcCtD
Almotriptan—Asthenia—Valproic Acid—epilepsy syndrome	3.69e-05	0.000215	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.68e-05	0.000214	CcSEcCtD
Almotriptan—Fatigue—Gabapentin—epilepsy syndrome	3.67e-05	0.000214	CcSEcCtD
Almotriptan—Body temperature increased—Pregabalin—epilepsy syndrome	3.67e-05	0.000214	CcSEcCtD
Almotriptan—Abdominal pain—Pregabalin—epilepsy syndrome	3.67e-05	0.000214	CcSEcCtD
Almotriptan—Dry mouth—Topiramate—epilepsy syndrome	3.66e-05	0.000213	CcSEcCtD
Almotriptan—Pain—Gabapentin—epilepsy syndrome	3.64e-05	0.000212	CcSEcCtD
Almotriptan—Pruritus—Valproic Acid—epilepsy syndrome	3.63e-05	0.000212	CcSEcCtD
Almotriptan—Confusional state—Topiramate—epilepsy syndrome	3.61e-05	0.00021	CcSEcCtD
Almotriptan—Shock—Topiramate—epilepsy syndrome	3.53e-05	0.000205	CcSEcCtD
Almotriptan—Diarrhoea—Valproic Acid—epilepsy syndrome	3.52e-05	0.000205	CcSEcCtD
Almotriptan—Nervous system disorder—Topiramate—epilepsy syndrome	3.51e-05	0.000205	CcSEcCtD
Almotriptan—Feeling abnormal—Gabapentin—epilepsy syndrome	3.51e-05	0.000204	CcSEcCtD
Almotriptan—Tachycardia—Topiramate—epilepsy syndrome	3.5e-05	0.000204	CcSEcCtD
Almotriptan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.48e-05	0.000203	CcSEcCtD
Almotriptan—Skin disorder—Topiramate—epilepsy syndrome	3.48e-05	0.000203	CcSEcCtD
Almotriptan—Hyperhidrosis—Topiramate—epilepsy syndrome	3.46e-05	0.000202	CcSEcCtD
Almotriptan—Hypersensitivity—Pregabalin—epilepsy syndrome	3.42e-05	0.000199	CcSEcCtD
Almotriptan—Dizziness—Valproic Acid—epilepsy syndrome	3.4e-05	0.000198	CcSEcCtD
Almotriptan—Body temperature increased—Gabapentin—epilepsy syndrome	3.37e-05	0.000196	CcSEcCtD
Almotriptan—Abdominal pain—Gabapentin—epilepsy syndrome	3.37e-05	0.000196	CcSEcCtD
Almotriptan—Asthenia—Pregabalin—epilepsy syndrome	3.33e-05	0.000194	CcSEcCtD
Almotriptan—Pruritus—Pregabalin—epilepsy syndrome	3.29e-05	0.000191	CcSEcCtD
Almotriptan—Vomiting—Valproic Acid—epilepsy syndrome	3.27e-05	0.00019	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.26e-05	0.00019	CcSEcCtD
Almotriptan—Insomnia—Topiramate—epilepsy syndrome	3.24e-05	0.000189	CcSEcCtD
Almotriptan—Rash—Valproic Acid—epilepsy syndrome	3.24e-05	0.000189	CcSEcCtD
Almotriptan—Dermatitis—Valproic Acid—epilepsy syndrome	3.24e-05	0.000189	CcSEcCtD
Almotriptan—Headache—Valproic Acid—epilepsy syndrome	3.22e-05	0.000187	CcSEcCtD
Almotriptan—Paraesthesia—Topiramate—epilepsy syndrome	3.22e-05	0.000187	CcSEcCtD
Almotriptan—Dyspnoea—Topiramate—epilepsy syndrome	3.19e-05	0.000186	CcSEcCtD
Almotriptan—Somnolence—Topiramate—epilepsy syndrome	3.19e-05	0.000186	CcSEcCtD
Almotriptan—Diarrhoea—Pregabalin—epilepsy syndrome	3.18e-05	0.000185	CcSEcCtD
Almotriptan—Dyspepsia—Topiramate—epilepsy syndrome	3.15e-05	0.000184	CcSEcCtD
Almotriptan—Hypersensitivity—Gabapentin—epilepsy syndrome	3.14e-05	0.000183	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.09e-05	0.00018	CcSEcCtD
Almotriptan—Fatigue—Topiramate—epilepsy syndrome	3.09e-05	0.00018	CcSEcCtD
Almotriptan—Dizziness—Pregabalin—epilepsy syndrome	3.07e-05	0.000179	CcSEcCtD
Almotriptan—Pain—Topiramate—epilepsy syndrome	3.06e-05	0.000178	CcSEcCtD
Almotriptan—Asthenia—Gabapentin—epilepsy syndrome	3.06e-05	0.000178	CcSEcCtD
Almotriptan—Nausea—Valproic Acid—epilepsy syndrome	3.05e-05	0.000178	CcSEcCtD
Almotriptan—Pruritus—Gabapentin—epilepsy syndrome	3.01e-05	0.000176	CcSEcCtD
Almotriptan—Vomiting—Pregabalin—epilepsy syndrome	2.95e-05	0.000172	CcSEcCtD
Almotriptan—Feeling abnormal—Topiramate—epilepsy syndrome	2.95e-05	0.000172	CcSEcCtD
Almotriptan—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.93e-05	0.000171	CcSEcCtD
Almotriptan—Rash—Pregabalin—epilepsy syndrome	2.93e-05	0.000171	CcSEcCtD
Almotriptan—Dermatitis—Pregabalin—epilepsy syndrome	2.93e-05	0.00017	CcSEcCtD
Almotriptan—Diarrhoea—Gabapentin—epilepsy syndrome	2.91e-05	0.00017	CcSEcCtD
Almotriptan—Headache—Pregabalin—epilepsy syndrome	2.91e-05	0.000169	CcSEcCtD
Almotriptan—Abdominal pain—Topiramate—epilepsy syndrome	2.83e-05	0.000165	CcSEcCtD
Almotriptan—Body temperature increased—Topiramate—epilepsy syndrome	2.83e-05	0.000165	CcSEcCtD
Almotriptan—Dizziness—Gabapentin—epilepsy syndrome	2.82e-05	0.000164	CcSEcCtD
Almotriptan—Nausea—Pregabalin—epilepsy syndrome	2.76e-05	0.000161	CcSEcCtD
Almotriptan—Vomiting—Gabapentin—epilepsy syndrome	2.71e-05	0.000158	CcSEcCtD
Almotriptan—Rash—Gabapentin—epilepsy syndrome	2.69e-05	0.000156	CcSEcCtD
Almotriptan—Dermatitis—Gabapentin—epilepsy syndrome	2.68e-05	0.000156	CcSEcCtD
Almotriptan—Headache—Gabapentin—epilepsy syndrome	2.67e-05	0.000155	CcSEcCtD
Almotriptan—Hypersensitivity—Topiramate—epilepsy syndrome	2.64e-05	0.000154	CcSEcCtD
Almotriptan—Asthenia—Topiramate—epilepsy syndrome	2.57e-05	0.00015	CcSEcCtD
Almotriptan—Pruritus—Topiramate—epilepsy syndrome	2.53e-05	0.000148	CcSEcCtD
Almotriptan—Nausea—Gabapentin—epilepsy syndrome	2.53e-05	0.000147	CcSEcCtD
Almotriptan—Diarrhoea—Topiramate—epilepsy syndrome	2.45e-05	0.000143	CcSEcCtD
Almotriptan—Dizziness—Topiramate—epilepsy syndrome	2.37e-05	0.000138	CcSEcCtD
Almotriptan—Vomiting—Topiramate—epilepsy syndrome	2.28e-05	0.000133	CcSEcCtD
Almotriptan—Rash—Topiramate—epilepsy syndrome	2.26e-05	0.000132	CcSEcCtD
Almotriptan—Dermatitis—Topiramate—epilepsy syndrome	2.26e-05	0.000131	CcSEcCtD
Almotriptan—Headache—Topiramate—epilepsy syndrome	2.24e-05	0.000131	CcSEcCtD
Almotriptan—Nausea—Topiramate—epilepsy syndrome	2.13e-05	0.000124	CcSEcCtD
Almotriptan—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	5.95e-06	8.54e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	5.95e-06	8.54e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	5.94e-06	8.53e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—HMOX1—epilepsy syndrome	5.94e-06	8.53e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	5.87e-06	8.43e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—S100B—epilepsy syndrome	5.87e-06	8.42e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AQP1—epilepsy syndrome	5.87e-06	8.42e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CAT—epilepsy syndrome	5.86e-06	8.42e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.82e-06	8.36e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.82e-06	8.36e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.82e-06	8.36e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.82e-06	8.36e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.82e-06	8.36e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SOCS3—epilepsy syndrome	5.81e-06	8.34e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDC42—epilepsy syndrome	5.8e-06	8.32e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—S100B—epilepsy syndrome	5.75e-06	8.25e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NT5E—epilepsy syndrome	5.72e-06	8.21e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALAD—epilepsy syndrome	5.72e-06	8.21e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ABCB1—epilepsy syndrome	5.7e-06	8.19e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SOCS3—epilepsy syndrome	5.69e-06	8.17e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDC42—epilepsy syndrome	5.68e-06	8.15e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.64e-06	8.09e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AVP—epilepsy syndrome	5.61e-06	8.06e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	5.61e-06	8.05e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.56e-06	7.98e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.54e-06	7.95e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AVP—epilepsy syndrome	5.5e-06	7.89e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	5.46e-06	7.84e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	5.46e-06	7.83e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	5.46e-06	7.83e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	5.43e-06	7.8e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.43e-06	7.79e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.4e-06	7.75e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	5.34e-06	7.67e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.33e-06	7.65e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.33e-06	7.65e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.33e-06	7.65e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HES1—epilepsy syndrome	5.31e-06	7.62e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.31e-06	7.62e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.31e-06	7.62e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GPX1—epilepsy syndrome	5.3e-06	7.61e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ADSL—epilepsy syndrome	5.23e-06	7.51e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HES1—epilepsy syndrome	5.2e-06	7.46e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FYN—epilepsy syndrome	5.16e-06	7.41e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—H2AFX—epilepsy syndrome	5.14e-06	7.38e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MEF2C—epilepsy syndrome	5.13e-06	7.37e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GLUL—epilepsy syndrome	5.13e-06	7.36e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.13e-06	7.36e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FYN—epilepsy syndrome	5.05e-06	7.25e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	5.04e-06	7.23e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—H2AFX—epilepsy syndrome	5.04e-06	7.23e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MEF2C—epilepsy syndrome	5.03e-06	7.22e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—YWHAZ—epilepsy syndrome	4.96e-06	7.12e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.95e-06	7.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.95e-06	7.11e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.94e-06	7.09e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NGF—epilepsy syndrome	4.91e-06	7.04e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	4.9e-06	7.04e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	4.88e-06	7.01e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	4.88e-06	7.01e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—YWHAZ—epilepsy syndrome	4.86e-06	6.97e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	4.85e-06	6.96e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.84e-06	6.95e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NGF—epilepsy syndrome	4.8e-06	6.9e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCR5—epilepsy syndrome	4.77e-06	6.85e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	4.72e-06	6.78e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	4.71e-06	6.76e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	4.69e-06	6.74e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCR5—epilepsy syndrome	4.67e-06	6.71e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR2A—epilepsy syndrome	4.67e-06	6.7e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	4.67e-06	6.7e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.66e-06	6.69e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.66e-06	6.68e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AGT—epilepsy syndrome	4.65e-06	6.68e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—BCHE—epilepsy syndrome	4.65e-06	6.67e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR2A—epilepsy syndrome	4.57e-06	6.56e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AQP1—epilepsy syndrome	4.57e-06	6.56e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—APOE—epilepsy syndrome	4.56e-06	6.54e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.53e-06	6.5e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TSC2—epilepsy syndrome	4.44e-06	6.37e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	4.43e-06	6.36e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AGT—epilepsy syndrome	4.43e-06	6.36e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.41e-06	6.34e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.41e-06	6.34e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.39e-06	6.3e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	4.38e-06	6.29e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—TH—epilepsy syndrome	4.37e-06	6.27e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TSC2—epilepsy syndrome	4.34e-06	6.24e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APOE—epilepsy syndrome	4.34e-06	6.23e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AGT—epilepsy syndrome	4.34e-06	6.23e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.33e-06	6.21e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KDR—epilepsy syndrome	4.25e-06	6.11e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APOE—epilepsy syndrome	4.25e-06	6.1e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.25e-06	6.1e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	4.24e-06	6.08e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.21e-06	6.05e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.21e-06	6.05e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.19e-06	6.01e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KDR—epilepsy syndrome	4.17e-06	5.98e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.16e-06	5.97e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	4.14e-06	5.94e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	4.14e-06	5.94e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.12e-06	5.92e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PRKCB—epilepsy syndrome	4.09e-06	5.88e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6ST—epilepsy syndrome	4.08e-06	5.85e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.04e-06	5.8e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	4.03e-06	5.79e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—BCHE—epilepsy syndrome	4.02e-06	5.77e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	4.01e-06	5.76e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	3.99e-06	5.73e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.98e-06	5.71e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.96e-06	5.68e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—POMC—epilepsy syndrome	3.91e-06	5.62e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.89e-06	5.58e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.88e-06	5.57e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.85e-06	5.53e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.85e-06	5.53e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	3.83e-06	5.5e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.79e-06	5.44e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	3.79e-06	5.44e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.78e-06	5.43e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TH—epilepsy syndrome	3.78e-06	5.42e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.77e-06	5.42e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—POMC—epilepsy syndrome	3.73e-06	5.35e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.72e-06	5.34e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	3.65e-06	5.24e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCL2—epilepsy syndrome	3.65e-06	5.24e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	3.65e-06	5.23e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.64e-06	5.22e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.6e-06	5.17e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CAT—epilepsy syndrome	3.6e-06	5.16e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.59e-06	5.15e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	3.57e-06	5.13e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ALB—epilepsy syndrome	3.57e-06	5.12e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.53e-06	5.07e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	3.5e-06	5.02e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.42e-06	4.91e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.38e-06	4.86e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	3.37e-06	4.84e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TH—epilepsy syndrome	3.37e-06	4.84e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.32e-06	4.76e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.31e-06	4.75e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	3.3e-06	4.73e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.3e-06	4.73e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	3.29e-06	4.72e-05	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKT1—epilepsy syndrome	3.28e-06	4.71e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	3.26e-06	4.69e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GPX1—epilepsy syndrome	3.25e-06	4.67e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.24e-06	4.65e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	3.23e-06	4.64e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.19e-06	4.58e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.19e-06	4.58e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	3.15e-06	4.52e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.15e-06	4.52e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—epilepsy syndrome	3.12e-06	4.48e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.11e-06	4.47e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CAT—epilepsy syndrome	3.11e-06	4.46e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TH—epilepsy syndrome	3.1e-06	4.45e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	3.06e-06	4.39e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	3.03e-06	4.34e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	3e-06	4.31e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	3e-06	4.3e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.96e-06	4.24e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.95e-06	4.23e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	2.94e-06	4.22e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AGT—epilepsy syndrome	2.85e-06	4.1e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.81e-06	4.04e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.81e-06	4.04e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.81e-06	4.03e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOE—epilepsy syndrome	2.8e-06	4.01e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.79e-06	4.01e-05	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	2.79e-06	4e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.78e-06	3.98e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	2.76e-06	3.96e-05	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.73e-06	3.92e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	2.7e-06	3.88e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.7e-06	3.88e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	2.68e-06	3.85e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.66e-06	3.83e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.64e-06	3.78e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	2.63e-06	3.77e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TH—epilepsy syndrome	2.63e-06	3.77e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	2.61e-06	3.75e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.6e-06	3.73e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.59e-06	3.71e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.59e-06	3.71e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	2.56e-06	3.67e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.55e-06	3.66e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.54e-06	3.64e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	2.53e-06	3.63e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.52e-06	3.62e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.51e-06	3.6e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.48e-06	3.56e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	2.48e-06	3.56e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.47e-06	3.54e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.42e-06	3.47e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	2.41e-06	3.45e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—POMC—epilepsy syndrome	2.4e-06	3.45e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	2.36e-06	3.38e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	2.34e-06	3.36e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.31e-06	3.31e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.29e-06	3.29e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.27e-06	3.26e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.2e-06	3.16e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.19e-06	3.15e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—epilepsy syndrome	2.19e-06	3.14e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.16e-06	3.11e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.16e-06	3.1e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.16e-06	3.1e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.16e-06	3.09e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.1e-06	3.02e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.08e-06	2.98e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.06e-06	2.95e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.03e-06	2.92e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TH—epilepsy syndrome	2.03e-06	2.91e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.02e-06	2.91e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.98e-06	2.85e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.96e-06	2.81e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	1.92e-06	2.75e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.89e-06	2.72e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.85e-06	2.66e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.72e-06	2.46e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.7e-06	2.45e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.69e-06	2.43e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.69e-06	2.42e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.68e-06	2.41e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.67e-06	2.4e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.66e-06	2.38e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.62e-06	2.33e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—epilepsy syndrome	1.57e-06	2.25e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.55e-06	2.23e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.51e-06	2.17e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	1.5e-06	2.15e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.48e-06	2.12e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	1.46e-06	2.1e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.44e-06	2.07e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.36e-06	1.95e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.32e-06	1.9e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.32e-06	1.89e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.3e-06	1.86e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.15e-06	1.65e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.11e-06	1.6e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.02e-06	1.46e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—epilepsy syndrome	9.63e-07	1.38e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.89e-07	1.28e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—epilepsy syndrome	8.32e-07	1.19e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—epilepsy syndrome	7.43e-07	1.07e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.83e-07	9.81e-06	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—epilepsy syndrome	5.79e-07	8.31e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.47e-07	6.41e-06	CbGpPWpGaD
